MP21-19 THE ANTISENSE LONG NON-CODING MITOCHONDRIAL RNA(AS-NCMTRNA) INTERFERENCE WITH ANDES-1537 AS A NOVEL TREATMENT FOR RENAL CARCINOMA

INTRODUCTION AND OBJECTIVES:Renal cell carcinoma (RCC) is the seventh most common cancer in men. Patients with distant metastasis have a 5 year survival rate of <10%. Metastatic RCC is resistant to...